Concepedia

Mark Tidswell

MT

Statistics

Publications

27

Citations

3.9K

H-Index

20

Active since

1984

Affiliations

Baystate Medical Center(Current)

University of California, San Francisco

University of Michigan

Intermountain Medical Center

Oregon Health & Science University

Mark Tidswell is an author at Baystate Medical Center specializing in medicine, acute respiratory distress syndrome, and pharmacotherapy.

ORCID

Publications per year

1984–2025

27

Publications

27

Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis

Steven M. Opal, Pierre‐François Laterre, Bruno François et al. · JAMA · 2013 · 795 citations · Full text

, , +11

A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome

Akram Khan, Cody Benthin, Brian Zeno et al. · Critical Care · 2017 · 631 citations · Full text

, , +15

Expression and function of the MAdCAM-1 receptor, integrin <i>alpha</i> 4 <i>beta</i> 7, on human leukocytes.

David J. Erle, Michael Briskin, E C Butcher et al. · The Journal of Immunology · 1994 · 355 citations · Full text

, , +17

Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock

Michael W. Donnino, Lars W. Andersen, Maureen Chase et al. · Critical Care Medicine · 2016 · 289 citations

, , +15

Selective expression of integrin <i>alpha</i> 4 <i>beta</i> 7 on a subset of human CD4+ memory T cells with Hallmarks of gut-trophism.

Tamás Schweighoffer, Yoichiro Tanaka, Mark Tidswell et al. · The Journal of Immunology · 1993 · 254 citations · Full text

, , +17

1–5 of 27